Intravitreal bevacizumab with regression of subretinal neovascularization after intraocular foreign body trauma.
Chen
Tun-Lu
TL
Department of Ophthalmology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kwei-Shan, Taoyuan, Taiwan.
Sun
Ming-Hui
MH
Lin
Ken-Kuo
KK
Lai
Chi-Chun
CC
Chen
Kuan-Jen
KJ
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D015807:Eye Injuries, Penetrating / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D005547:Foreign Bodies / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D056965:Injections, Intraocular; D008297:Male; D008875:Middle Aged; D011859:Radiography; D015861:Retinal Neovascularization / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D014822:Vitreous Body
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab